Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Vincent Makoundou"'
Autor:
Zoltan Pataky, A Casolaro, Alain Golay, Rafael Gabriel, Vincent Makoundou, Elisabetta Bobbioni-Harsch, Peter M. Nilsson, Elza Muscelli, Katarina Lalic
Publikováno v:
International Journal of Obesity and Related Metabolic Disorders, Vol. 35, No 9 (2011) pp. 1208-1215
Objectives: The objective of this study was to define metabolic normality and to investigate the cardiometabolic profile of metabolically normal obese. Design: Cross-sectional study conducted at 21 research centers in Europe. Subjects: Normal body we
Autor:
Vincent Makoundou, Fabrizio Montecucco, Elisabetta Harsch, Thomas H. Schindler, Gabriella Vincenti, Alessandra Quercioli, Zoltan Pataky, Aurélien Thomas, Vincenzo Di Marzo, Christian Staub, Yann Seimbille, Osman Ratib, Sebastian Carballo, François Mach, Sabine Steffens, Alain Golay
Publikováno v:
European heart journal
European heart journal 32 (2011): 1369–1378.
info:cnr-pdr/source/autori:Quercioli A, Pataky Z, Vincenti G, Makoundou V, Di Marzo V, Montecucco F, Carballo S, Thomas A, Staub C, Steffens S, Seimbille Y, Golay A, Ratib O, Harsch E, Mach F, Schindler TH./titolo:Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity/doi:/rivista:European heart journal/anno:2011/pagina_da:1369/pagina_a:1378/intervallo_pagine:1369–1378/volume:32
European Heart Journal, Vol. 32, No 11 (2011) pp. 1369-1378
European heart journal 32 (2011): 1369–1378.
info:cnr-pdr/source/autori:Quercioli A, Pataky Z, Vincenti G, Makoundou V, Di Marzo V, Montecucco F, Carballo S, Thomas A, Staub C, Steffens S, Seimbille Y, Golay A, Ratib O, Harsch E, Mach F, Schindler TH./titolo:Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity/doi:/rivista:European heart journal/anno:2011/pagina_da:1369/pagina_a:1378/intervallo_pagine:1369–1378/volume:32
European Heart Journal, Vol. 32, No 11 (2011) pp. 1369-1378
Aims Aim of this study was to evaluate a possible association between endocannabinoid (EC) plasma levels, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and coronary circulatory function in obesity. Methods and results Myocardial blood f
Fat distribution influences the cardio-metabolic profile in a clinically healthy European population
Autor:
Zoltan Pataky, M. Kozakova, Alain Golay, Elisabetta Bobbioni-Harsch, Vincent Makoundou, J. Dekker
Publikováno v:
European Journal of Clinical Investigation, 39(12), 1055-1064
Bobbioni-Harsch, E, Pataky, Z, Makoundou, V, Kozakova, M, Dekker, J & Golay, A 2009, ' Fat distribution influences the cardio-metabolic profile in a clinically healthy European population ', European Journal of Clinical Investigation, vol. 39, no. 12, pp. 1055-1064 . https://doi.org/10.1111/j.1365-2362.2009.02211.x
European Journal of Clinical Investigation, Vol. 39, No 12 (2009) pp. 1055-1064
Bobbioni-Harsch, E, Pataky, Z, Makoundou, V, Kozakova, M, Dekker, J & Golay, A 2009, ' Fat distribution influences the cardio-metabolic profile in a clinically healthy European population ', European Journal of Clinical Investigation, vol. 39, no. 12, pp. 1055-1064 . https://doi.org/10.1111/j.1365-2362.2009.02211.x
European Journal of Clinical Investigation, Vol. 39, No 12 (2009) pp. 1055-1064
BACKGROUND AND AIMS: Waist and hip circumferences are largely influenced by Fat Mass and several other determinants. To evaluate the specific effects of a preferential fat distribution, we corrected the waist and hip circumferences for all their dete
Autor:
Philippe Morel, Olivier Huber, Elisabetta Bobbioni-Harsch, Juan Sztajzel, Alain Golay, V. Barthassat, Katia Sievert, Vincent Makoundou, Gilles Chassot, Françoise Assimacopoulos-Jeannet, Giacomo Gastaldi
Publikováno v:
Obesity, Vol. 17, No 2 (2009) pp. 247-253
In order to investigate the improvement of insulin resistance and cardiac autonomic function along massive weight loss, 12 obese women were evaluated before, and 3 and 12 months after Roux-en-Y gastric bypass. The 12-month values were compared to tho
Autor:
Elisabetta Bobbioni Harsch, Zoltan, Pataky, Vincent, Makoundou, Martine, Laville, Emmanuel, Disse, Christian, Anderwald, Thomas, Konrad, Alain, Golay, Heine, Rj, Dekker, J, Nijpels, G, Boorsma, W, Mitrakou, A, Tournis, S, Kyriakopoulou, K, Thomakos, P, Lalic, N, Lalic, K, Jotic, A, Lukic, L, Civcic, M, Nolan, J, Yeow, Tp, Murphy, M, Delong, C, Neary, G, Colgan, Mp, Hatunic, M, Konrad, T, Böhles, H, Fuellert, S, Baer, F, Zuchhold, H, Golay, A, Harsch Bobbioni, E, Pataky, Z, Petrie, Jr, Perry, C, Neary, F, Macdougall, C, Shields, K, Malcolm, L, Laakso, M, Salmenniemi, U, Aura, A, Raisanen, R, Ruotsalainen, U, Sistonen, T, Laitinen, M, Saloranta, H, Coppack, Sw, Mcintosh, N, Khadobaksh, P, Laville, M, Bonnet, F, Brac de la Perriere, A, Louche Pelissier, C, Maitrepierre, C, Peyrat, J, Serusclat, A, Gabriel, R, Sánchez, Em, Carraro, R, Friera, A, Novella, B, Nilsson, P, Persson, M, Östling, G, Melander, O, Burri, P, Piatti, Pm, Monti, Ld, Setola, E, Galluccio, E, Minicucci, F, Colleluori, A, Walker, M, Ibrahim, Im, Jayapaul, M, Carman, D, Short, K, Mcgrady, Y, Richardson, D, Beck Nielsen, H, Staehr, P, Hojlund, K, Vestergaard, V, Olsen, C, Hansen, L, Bolli, Geremia Brunetto, Porcellati, Francesca, Fanelli, Carmine Giuseppe, Lucidi, Paola, Calcinaro, F, Saturni, A, Ferrannini, E, Natali, A, Muscelli, E, Pinnola, S, Kozakova, M, Mingrone, G, Guidone, C, Favuzzi, A, Di Rocco, P, Anderwald, C, Bischof, M, Promintzer, M, Krebs, M, Mandl, M, Hofer, A, Luger, A, Waldhäusl, W, Roden, M, Balkau, B, Dekker, Jm, Mari, A, Gaffney, P, Boran, G, Kok, A, Patel, S, Gastaldelli, A, Ciociaro, D, Guillanneuf, Mt, Mhamdi, L, Pacini, G, Cavaggion, C, Hills, Sa, Landucci, L, Mota, L.
Publikováno v:
Obesity, Vol. 20, No 10 (2012) pp. 2063-2069
The aim of the study was to evaluate the 3 years incidence of cardiometabolic risk factors, such as impaired fasting glucose, reduced high-density lipoprotein (HDL)-cholesterol, increased plasma triglycerides or blood pressure as well as impaired glu
Autor:
Jean Pierre Gachoud, Elisabetha Bobbioni-Harsch, Alain Golay, Vincent Makoundou, Zoltan Pataky
Publikováno v:
Obesity Facts, Vol. 4, No 3 (2011) pp. 218-221
Objective: To compare the metabolic cardiovascular risk factors of obese patients after weight loss and 4-year weight loss maintenance afterwards against a matched control group of subjects with a stable body weight and without history of weight loss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ccf1f74f5bce479931e35eec2310306
https://europepmc.org/articles/PMC6444611/
https://europepmc.org/articles/PMC6444611/
Autor:
Zoltan Pataky, Franck Habicht, Alain Golay, Jean Pierre Gachoud, Elisabetha Bobbioni-Harsch, Vincent Makoundou
Publikováno v:
Obesity Facts, Vol. 4, No 3 (2011) pp. 191-196
AIM: To assess the efficacy of a specific long-term programme for weight loss maintenance using a new ‘on/off’ Orlistat approach in obese subjects who previously lost more than 10% of their body weight. METHODS: 50 patients were followed up durin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8199e4bab7a90ad668c2fc80d564d6
https://archive-ouverte.unige.ch/unige:25812
https://archive-ouverte.unige.ch/unige:25812
Autor:
J.-P. Gachoud, Zoltan Pataky, F. Habicht, Alain Golay, Vincent Makoundou, Elisabetta Bobbioni-Harsch
Publikováno v:
Eating and weight disorders : EWD. 15(1-2)
The overarching problem in the treatment of obesity is the consistency with which weight in treatment is regained. The aim of this study is to follow-up the patient using a multifactor approach (cognitive-behavioral therapies, diet and physical activ
Publikováno v:
Revue medicale suisse. 5(196)
Obesity is a recognized risk factor for cardiovascular diseases. As evaluated by body mass index (BMI), obesity is associated with increased morbidity and mortality due to chronic diseases, like type 2 diabetes, coronary artery disease and stroke. It